Two Hot Stocks Comparison: Bloom Energy Corporation (NYSE:BE), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

earnings estimates

Bloom Energy Corporation (NYSE:BE)

Bloom Energy Corporation (NYSE:BE) closed at $10.06 on the last trading session with an decrease of -2.8%, whereas, it previously closed at $10.35. The company has a market capitalization of $1.13 Billion. The company traded shares of 860705 on the trading day while its three month average volume stands at 648.73 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Bloom Energy Corporation (NYSE:BE) produced diluted EPS of -2.23. The EPS estimate for next year as estimated by analysts is at 0.29 while EPS for next quarter is estimated at -0.18. Earnings per Share growth for this year is reported at 6.1, while the analysts estimated the EPS growth for next year at 0.29% and Earnings growth for next 5 years stands at 25% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Bloom Energy Corporation (NYSE:BE) is at 0 while the forward p/e is at 34.22. The P/S or Price to Sales ratio of Bloom Energy Corporation (NYSE:BE) stands at 1.53 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Bloom Energy Corporation (NYSE:BE) are reported at 2.1 and 2.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Bloom Energy Corporation (NYSE:BE) stands at -16.2, 12.2 and 12.7 respectively

The trailing twelve month Revenue of Bloom Energy Corporation (NYSE:BE) is reported at 742 Million with income of -241800000. The outstanding shares of Bloom Energy Corporation (NYSE:BE) are 112.57 Million. The institutional Ownership of the shares of 2.24 stands at 0.80%, this figure is increased 100.56 in the last six months. The insider ownership for the shares of Bloom Energy Corporation (NYSE:BE) is ticked at 1.8%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Bloom Energy Corporation (NYSE:BE) is the Mean Target Price estimated by the analysts which stands at 22.43. The 52 week high of Bloom Energy Corporation (NYSE:BE) is placed at 38.00 and 52 week low is standing at 8.88.

Performance wise the shares of Bloom Energy Corporation (NYSE:BE) fell down -1.66% for the week, it also fell -17.13% for the monthly performance, while for the quarter it went up -41.68%. The shares decrease -64.26% for the half year and flew up for the Year-To-Date performance. The shares of Bloom Energy Corporation (NYSE:BE) grew 0% for the yearly performance.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) closed at $94.28 on the last trading session with an increase of 0.55%, whereas, it previously closed at $93.76. The company has a market capitalization of $16.73 Billion. The company traded shares of 598287 on the trading day while its three month average volume stands at 919.55 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) produced diluted EPS of -0.5. The EPS estimate for next year as estimated by analysts is at -0.05 while EPS for next quarter is estimated at -0.24. Earnings per Share growth for this year is reported at 88.7, while the analysts estimated the EPS growth for next year at -0.05% and Earnings growth for next 5 years stands at 47.2% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 14.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands at 11.18 and Price to Book or P/B for the most recent quarter stands at 5.74. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) are reported at 2.3 and 2.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands at -2.7, -4.4 and -1.3 respectively

The trailing twelve month Revenue of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is reported at 1.5 Billion with income of -87300000. The outstanding shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) are 177.48 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 0.08 in the last six months. The insider ownership for the shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is ticked at 0.5%, the figure is plummeted -11.36% in the last six months.

Some other important financial aspects to be discussed here for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is the Mean Target Price estimated by the analysts which stands at 121.14. The 52 week high of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is placed at 106.74 and 52 week low is standing at 75.81.

Performance wise the shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) fell down -4.4% for the week, it also rise 3.76% for the monthly performance, while for the quarter it went up -2.38%. The shares decrease -8.75% for the half year and flew up for the Year-To-Date performance. The shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) grew 10.92% for the yearly performance.